Cross-talk between the kidney and the cardiovascular system
- PMID: 16825329
- DOI: 10.1681/ASN.2006030204
Cross-talk between the kidney and the cardiovascular system
Abstract
In recent years, increasing evidence has been provided that even minor renal dysfunction is a powerful cardiovascular risk factor that induces typical cardiovascular alterations and thus predisposes to coronary heart disease as well as to noncoronary cardiovascular problems. This first had been noted in patients with diabetes but now has been confirmed amply in patients without diabetes as well. Numerous heterogeneous abnormalities have been described in patients with early renal dysfunction (e.g., microalbuminuria, reduced estimated GFR). One final common pathway seems to be endothelial cell dysfunction. The link between albuminuria and generalized endothelial cell dysfunction (as indicated by diminished flow-mediated vasodilation, markers of endothelial cell dysfunction, sloughed off endothelial cells, and high transcapillary albumin escape rate) is unclear. In patients with early renal dysfunction, a long list of classical and nonclassical cardiovascular risk factors have been identified: Elevated asymmetric dimethyl-l-arginine concentrations, markers of microinflammation, oxidative stress, features of metabolic syndrome, abnormal adipokine concentrations, dyslipidemia, inappropriate activation of the renin-angiotensin system, and sympathetic overactivity. The mechanisms that link dysfunction of the kidney and the cardiovascular system are being sought. The most interesting unifying concept, however, is deranged fetal programming linking nephron underdosing to the increased cardiovascular risk.
Similar articles
-
Microalbuminuria, endothelial dysfunction and cardiovascular risk.Diabetes Metab. 2000 Jul;26 Suppl 4:64-6. Diabetes Metab. 2000. PMID: 10922975 Review.
-
Endothelial dysfunction and chronic kidney disease: treatment options.Curr Opin Investig Drugs. 2008 Sep;9(9):970-82. Curr Opin Investig Drugs. 2008. PMID: 18729004 Review.
-
[Chronic renal disease as cardiovascular risk factor].Ned Tijdschr Geneeskd. 2008 Jul 19;152(29):1614-8. Ned Tijdschr Geneeskd. 2008. PMID: 18998268 Review. Dutch.
-
Renal dysfunction and coronary disease: a high-risk combination.J Nephrol. 2009 Jan-Feb;22(1):39-45. J Nephrol. 2009. PMID: 19229817 Review.
-
[Inflammation, oxidative stress and kidney function in arterial hypertension].G Ital Nefrol. 2009 Jul-Aug;26 Suppl 46:8-13. G Ital Nefrol. 2009. PMID: 19644813 Italian.
Cited by
-
Circulatory syndrome: an evolution of the metabolic syndrome concept!Curr Cardiol Rev. 2012 Feb;8(1):68-76. doi: 10.2174/157340312801215773. Curr Cardiol Rev. 2012. PMID: 22845817 Free PMC article. Review.
-
Microinflammation factors in the common diseases of the heart and kidneys.Dis Markers. 2015;2015:470589. doi: 10.1155/2015/470589. Epub 2015 Jan 14. Dis Markers. 2015. PMID: 25648331 Free PMC article.
-
The association of exercise and sedentary behaviours with incident end-stage renal disease: the Southern Community Cohort Study.BMJ Open. 2019 Aug 30;9(8):e030661. doi: 10.1136/bmjopen-2019-030661. BMJ Open. 2019. PMID: 31471443 Free PMC article.
-
Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues.Sci Rep. 2016 Nov 8;6:36205. doi: 10.1038/srep36205. Sci Rep. 2016. PMID: 27824084 Free PMC article.
-
Midkine regulation of the renin-angiotensin system.Curr Hypertens Rep. 2010 Apr;12(2):74-9. doi: 10.1007/s11906-010-0092-8. Curr Hypertens Rep. 2010. PMID: 20424942 Review.
MeSH terms
LinkOut - more resources
Full Text Sources